Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
Abstract Background Although amyloid PET of typical Alzheimer’s disease (AD) shows diffuse ß-amyloid (Aß) deposition, some patients show focal deposition. The clinical significance of this focal Aß is not well understood. We examined the clinical significance of focal Aß deposition in terms of cogni...
Main Authors: | Si Eun Kim, Byungju Lee, Seongbeom Park, Soo Hyun Cho, Seung Joo Kim, Yeshin Kim, Hyemin Jang, Jee Hyang Jeong, Soo Jin Yoon, Kyung Won Park, Eun-Joo Kim, Na Yeon Jung, Bora Yoon, Jae-Won Jang, Jin Yong Hong, Jihye Hwang, Duk L. Na, Sang Won Seo, Seong Hye Choi, Hee Jin Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-019-0577-x |
Similar Items
-
Cognitive trajectories of patients with focal ß-amyloid deposition
by: Si Eun Kim, et al.
Published: (2021-02-01) -
Clinical outcomes of increased focal amyloid uptake in individuals with subthreshold global amyloid levels
by: Jaeho Kim, et al.
Published: (2023-03-01) -
Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben
by: Hye Joo Son, et al.
Published: (2018-07-01) -
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
by: Hugh G. Pemberton, et al.
Published: (2023-05-01) -
Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
by: Milos D. Ikonomovic, et al.
Published: (2018-06-01)